Description
A Phase III Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Fenebrutinib Compared With Ocrelizumab In Adult Patients With Primary Progressive Multiple Sclerosis
Location: REDI (East Bay); Sutter East Bay Medical Foundation
Please contact: Canary Jumawan about GN41791
Principal Investigator
David Eric Collins, MD, Joanna A. Cooper, M.D.
Co-Investigator(s)
Aryn Earnhardt, NP, Bradley T Wrubel, MD, Lynn Jehle, NP, Matthew W. Arnold, M.D., Antonio J Silva-Sayago, MD